Hras

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

H-RAS

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

HRAS is the acronym for "Harvey-Rat-Sarcoma". The Harvey-Rat-Sarcoma protein belongs to the family of RAS proteins (see RAS below) and was first identified as a transforming oncogene in 1982.

General informationThis section has been translated automatically.

HRas acts as a central switch point in a number of signal transduction pathways involved in the regulation of cell growth and differentiation. This key role in the development of tumours has made the HRas protein an important target in the development of oncological drugs. Mutations in the encoding HRAS gene lead to a pathological gene product.

Note(s)This section has been translated automatically.

The sebaceous nevus is caused by postzygotic HRAS mutations in 95% of cases. HRAS mutations are also found in Schimmelpenning syndrome (sebaceous nevus in combination with ophthalmological, CNS disorders, osseous and cardiac malformations) in the organoid nevus of the skin and in the affected organs (Groesser L et al. 2012). Postzygotic HRAS mutations are also found in phacomatosis pigmentokeratotica in both the organoid and melanocytic nevus.

LiteratureThis section has been translated automatically.

  1. Groesser L et al (2012) Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome.Nat Genet 44:783-787.
  2. Groesser L et al (2013) Phacomatosis pigmentokeratotica is caused by a postzygotic HRAS mutation in a multipotent progenitor cell. J Invest Dermatol 133:1998-2003.

Authors

Last updated on: 29.10.2020